`Filed: January 6, 2017
`
`Filed on behalf of Teva Pharmaceuticals USA, Inc.
`By: Gary J. Speier
`
`Mark D. Schuman
`CARLSON, CASPERS, VANDENBURGH,
`
`
`LINDQUIST & SCHUMAN, P.A.
`
`225 South Sixth Street, Suite 4200
`
`Minneapolis, MN 55402
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`TEVA PHARMACEUTICALS USA, INC.
`Petitioner,
`
`v.
`
`ALLERGAN, INC.,
`Patent Owner.
`
`
`
`Case No. IPR2017-00583
`Patent No. 8,633,162
`
`
`
`PETITIONER TEVA PHARMACEUTICALS USA INC.’S POWER OF
`ATTORNEY PURSUANT TO 37 C.F.R. §42.10(b)
`
`Submitted with
`PETITION FOR INTER PARTES REVIEW OF PATENT NO. 8,633,162
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F .R. § 42. l O(b ), Petitioner TEVA PHARMACEUTICALS,
`
`USA, INC. hereby appoints the practitioners associated with Carlson, Caspers,
`
`Vandenburgh, Lindquist & Schuman, P.A., Customer Number 38846, including
`
`the following lead and back-up counsel, as its attorneys to transact all business in
`
`the United States Patent and Trademark Office associated with a petition for inter
`
`partes review of U.S. Patent No. 8,633,162.
`
`Lead Counsel
`
`Back-Up Counsel
`
`Gary J. Speier
`USPTO Reg. No. 45,458
`Carlson, Caspers, Vandenburgh,
`Lindquist & Schuman, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Tel: (612) 436-9600
`Fax: (612) 436-9605
`Email: s eier carlsoncas ers.com
`
`Mark D. Schuman
`USPTO Reg. No. 31,197
`Carlson, Caspers, Vandenburgh,
`Lindquist & Schuman, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Tel: (612) 436-9600
`Fax: (612) 436-9605
`Email: mschuman carlsoncas ers.com
`
`By: ____ ~_Ji_, _f ~--\---
`For: Petitioner Teva Pharmaceuticals, USA, Inc.
`
`Name:
`
`Title:
`
`Date:
`
`j'1ftJ <r-t2EI J
`/(1v1<A-
`---------------
`Crel'\..t.r,. I Co .J.rl .s.i. I
`!}11 O c..10. k
`
`l / '"f Jr 't